In light of the extenuating weather conditions and power outages in multiple states, the Deadline to Apply for the 2023 AIM-HI Women's Venture Competition has been extended to Sunday, March 19, at 11:55 PM EST! Launched by the AIM-HI Accelerator…
If AngeLink has a guardian angel, she may well be Dr. Sujuan Ba, Ph.D., who was recently featured as One of the 20 Most Inspiring Women Leaders of 2022 by The Women Leaders Magazine. “Sujuan believed in my vision for…
Have you heard? The application for the 2023 AIM-HI Women's Venture Competition is now open to women-led, early-stage oncology companies worldwide! Launched by the AIM-HI Accelerator Fund (AIM-HI) in 2020, this one-of-its-kind annual competition empowers women scientist-entrepreneurs in oncology by…
The AIM-HI Accelerator Fund (AIM-HI), together with our partner organizations, the National Foundation for Cancer Research and the Asian Fund for Cancer Research, successfully concluded the 2022 Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship on Saturday, October…
ROCKVILLE, MD – The AIM-HI Accelerator Fund (AIM-HI) today announced the recipient of its inaugural Beacon Award for Women Leaders in Oncology as Anna D. Barker, Ph.D., Chief Strategy Officer at the Lawrence J. Ellison Institute for Transformative Medicine. She…
The AIM-HI Accelerator Fund (AIM-HI) brings together a worldwide community of leaders in oncology to bridge the gap between laboratory discoveries and clinical trials, with the ultimate goal of developing innovative cancer therapies and technologies that can save patients’ lives.…
The AIM-HI Accelerator Fund is honored to be nominated for the 2022 Prix Galien USA Incubators, Accelerators and Equity Award. The newest Prix Galien Award category, “Incubators, Accelerators and Equity,” acknowledges the role played by organizations in guiding the next…
ROCKVILLE, MD – AIM-HI Accelerator Fund, a non-for-profit that focuses on supporting early-stage biotechnology companies to progress innovative discoveries into the clinic, announced today that Mr. Lance Kawaguchi, CEO of Cure Brain Cancer Foundation, has been appointed as a strategic…
ROCKVILLE, MD – AIM-HI Accelerator Fund, a non-for-profit that focuses on supporting early-stage biotechnology companies to progress innovative discoveries into the clinic, announced today the launching of its first Beacon Award for Women Leaders in Oncology. This award will be an…
The AIM-HI Accelerator Fund (AIM-HI) just announced 6 Semi-Finalists for the 2022 AIM-HI Women’s Venture Competition! These innovative oncology start-ups have been selected from an exceptional pool of applications submitted by women scientist-entrepreneurs worldwide. The AIM-HI Women’s Venture Competition, now…
